📰 Daniel Speciale News
Page 2 - Daniel Speciale News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Speciale. Real-time updates on events, politics, business and more.
May 9, 2023
Advanced Launch of Terlivaz® with Rapid and Successful Uptake in Hospital Formulary Access and Continued Medical Community Interest Reports First Quarter Net...
February 28, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported results for...
February 16, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that Siggi Olafsson, President and Chief...
February 8, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that it will report fourth quarter 2022...
January 12, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that Dr....
November 16, 2022
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the recipient of 2022s Advancing...
November 16, 2022
-- Winning project hopes to unlock invaluable insights on how ECP could improve quality of life and clinical outcomes in chronic lung allograft dysfunction -- DUBLIN, Nov. 16, 2022 /PRNewswire/
November 8, 2022
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported results for...
October 24, 2022
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has...
October 18, 2022
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that it will report third quarter 2022 earnings...